They also compared the metabolic profiles of lispro and regular human insulin in persons with diet-unresponsive T2DM and compensated nonalcoholic liver disease and found that lispro caused lower postprandial glucose levels and hypoglycemic rates [6]. Here, INS is linked to type 2 diabetes mellitus.